Cargando…
Association of Group B Meningococcal Vaccine Receipt With Reduced Gonorrhea Incidence Among University Students
This case-control study examines reported cases of gonorrhea among recipients of meningococcal group B vaccine at 2 universities in Oregon.
Autores principales: | Robison, Steve G., Leman, Richard F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472183/ https://www.ncbi.nlm.nih.gov/pubmed/37651146 http://dx.doi.org/10.1001/jamanetworkopen.2023.31742 |
Ejemplares similares
-
A meningococcal B vaccine induces cross-protection against gonorrhea
por: Azze, Rolando Felipe Ochoa
Publicado: (2019) -
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
por: McNamara, Lucy A., et al.
Publicado: (2017) -
Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination
por: Parikh, Sydel R., et al.
Publicado: (2016) -
Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study
por: Paynter, Janine, et al.
Publicado: (2019) -
Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
por: Soeters, Heidi M., et al.
Publicado: (2017)